EUROPEAN JOURNAL OF MEDICAL AND EDUCATIONAL TECHNOLOGIES
The Convalescent Serum for Treatment of COVID-19 Infection: Review

Sadeq Kadhim Hachim 1 *

European Journal of Medical and Educational Technologies, Volume 13, Issue 1, Article No: em2005

https://doi.org/10.30935/ejmets/8016

OPEN ACCESS   172 Views   131 Downloads

Download Full Text (PDF)

Abstract

In the early of 2020, people are challenging a pandemic in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 causes coronavirus disease, abbreviated as COVID-19. At the time of this writing, SARS-CoV-2 is spreading in multiple countries worldwide. There are above two million cases in different region of world. This virus appears to be a new human pathogen. Currently there are no vaccines, monoclonal antibodies (mAbs), or drugs available for SARS-CoV-2, though many are in rapid development and some may be accessible in a short time. This aim of this review that human convalescent serum is an option for stoppage and treatment of COVID-19 disease. Explain main advantage of convalescent serum, in addition to disadvantage of this method.

References

Citation